The Cost Effectiveness of Antiretroviral Regimens for the Treatment of HIV/AIDS View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2000-10

AUTHORS

Aslam H. Anis, Daphne Guh, Robert S. Hogg, Xiao-Hua Wang, Benita Yip, Kevin J. P. Craib, Michael V. O’Shaughnessy, Martin T. Schechter, Julio S. G. Montaner

ABSTRACT

OBJECTIVE: To estimate survival, the number of life-years gained and cost effectiveness of antiretroviral therapy (ART) regimens, denoted as ERA-I [zidovudine + (didanosine or zalcitabine)]; ERA-II [stavudine + (didanosine or zalcitabine) or lamivudine + (zidovudine or didanosine or zalcitabine or stavudine)]; and ERA-III [2 nucleoside reverse transcriptase inhibitors + (1 protease inhibitor or 1 non-nucleoside reverse transcriptase inhibitor)]. DESIGN: Modelling of drug cost, cost of opportunistic diseases and survival of HIV positive men and women in the province of British Columbia who were first prescribed any ART between October 1992 and June 1996. A 'reference cohort' was modelled upon individuals in a longitudinal cohort of homosexual men followed since 1982. PERSPECTIVE AND SETTING: Third-party payer perspective in British Columbia, Canada. PATIENTS: All HIV-positive men and women aged > or =18 years with CD4+ counts < or =350 cells/microL who were enrolled in the province-wide drug treatment programme. MAIN OUTCOME MEASURES: Annual costs, survival and cost-effectiveness ratios of successive ART regimens. RESULTS: Total costs [1997 Canadian dollars ($Can)] at 12 months under ERA-I, -II and -III were $Can4897, $Can6620 and $Can 11 914, respectively. Survival at 12 months under ERA-I, -II and -III was 89.6%, 91.0% and 97.6%, respectively. The annual incremental cost (estimated by the total incremental cost at 12 months) between ERA-II and ERA-I was $Can1723. The incremental cost-effectiveness ratios between ERA-III and ERA-I, and between ERA-III and ERA-II were $Can58 806 and $Can46 971 per life-year gained, respectively. CONCLUSION: We found the cost effectiveness of ERA-III ART regimens well within the range of currently funded therapies for the treatment of other chronic diseases. More... »

PAGES

393-404

Identifiers

URI

http://scigraph.springernature.com/pub.10.2165/00019053-200018040-00007

DOI

http://dx.doi.org/10.2165/00019053-200018040-00007

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1024075285

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/15344307


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1117", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Public Health and Health Services", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Acquired Immunodeficiency Syndrome", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Anti-HIV Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cost-Benefit Analysis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Therapy, Combination", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Health Care Costs", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "University of British Columbia", 
          "id": "https://www.grid.ac/institutes/grid.17091.3e", 
          "name": [
            "British Columbia Centre for Excellence in HIV/AIDS, St. Paul\u2019s Hospital, Vancouver, British Columbia, Canada", 
            "Canadian HIV Trials Network, Vancouver, British Columbia, Canada", 
            "Department of Health Care and Epidemiology, University of British Columbia, Vancouver, British Columbia, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Anis", 
        "givenName": "Aslam H.", 
        "id": "sg:person.01340462506.44", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01340462506.44"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Canadian HIV Trials Network, Vancouver, British Columbia, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Guh", 
        "givenName": "Daphne", 
        "id": "sg:person.0654122412.16", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0654122412.16"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of British Columbia", 
          "id": "https://www.grid.ac/institutes/grid.17091.3e", 
          "name": [
            "British Columbia Centre for Excellence in HIV/AIDS, St. Paul\u2019s Hospital, Vancouver, British Columbia, Canada", 
            "Department of Health Care and Epidemiology, University of British Columbia, Vancouver, British Columbia, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hogg", 
        "givenName": "Robert S.", 
        "id": "sg:person.01057070102.49", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01057070102.49"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Canadian HIV Trials Network, Vancouver, British Columbia, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Wang", 
        "givenName": "Xiao-Hua", 
        "id": "sg:person.01133246574.60", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01133246574.60"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "St. Paul's Hospital", 
          "id": "https://www.grid.ac/institutes/grid.416553.0", 
          "name": [
            "British Columbia Centre for Excellence in HIV/AIDS, St. Paul\u2019s Hospital, Vancouver, British Columbia, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Yip", 
        "givenName": "Benita", 
        "id": "sg:person.01160746452.90", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01160746452.90"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Canadian HIV Trials Network, Vancouver, British Columbia, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Craib", 
        "givenName": "Kevin J. P.", 
        "id": "sg:person.01211241175.66", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01211241175.66"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of British Columbia", 
          "id": "https://www.grid.ac/institutes/grid.17091.3e", 
          "name": [
            "British Columbia Centre for Excellence in HIV/AIDS, St. Paul\u2019s Hospital, Vancouver, British Columbia, Canada", 
            "Canadian HIV Trials Network, Vancouver, British Columbia, Canada", 
            "Department of Pathology, University of British Columbia, Vancouver, British Columbia, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "O\u2019Shaughnessy", 
        "givenName": "Michael V.", 
        "id": "sg:person.0663251475.19", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0663251475.19"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of British Columbia", 
          "id": "https://www.grid.ac/institutes/grid.17091.3e", 
          "name": [
            "British Columbia Centre for Excellence in HIV/AIDS, St. Paul\u2019s Hospital, Vancouver, British Columbia, Canada", 
            "Canadian HIV Trials Network, Vancouver, British Columbia, Canada", 
            "Department of Health Care and Epidemiology, University of British Columbia, Vancouver, British Columbia, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Schechter", 
        "givenName": "Martin T.", 
        "id": "sg:person.016444275112.20", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016444275112.20"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of British Columbia", 
          "id": "https://www.grid.ac/institutes/grid.17091.3e", 
          "name": [
            "British Columbia Centre for Excellence in HIV/AIDS, St. Paul\u2019s Hospital, Vancouver, British Columbia, Canada", 
            "Canadian HIV Trials Network, Vancouver, British Columbia, Canada", 
            "Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Montaner", 
        "givenName": "Julio S. G.", 
        "id": "sg:person.015212221772.29", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015212221772.29"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.2165/00019053-199712010-00006", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003832056", 
          "https://doi.org/10.2165/00019053-199712010-00006"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00002030-198906000-00002", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004321333"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00002030-198906000-00002", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004321333"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.2165/00019053-199610020-00001", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005281811", 
          "https://doi.org/10.2165/00019053-199610020-00001"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0277-9536(93)90315-u", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009374126"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00002030-199803000-00005", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013608384"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00002030-199803000-00005", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013608384"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00002030-199803000-00005", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013608384"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00002030-199906180-00016", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020821681"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00002030-199906180-00016", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020821681"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00002030-199906180-00016", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020821681"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1017/s0266462300009247", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024918358"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/jama.1997.03540480062040", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028003169"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.2165/00019053-199610020-00002", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029089270", 
          "https://doi.org/10.2165/00019053-199610020-00002"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/jama.279.2.130", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045751367"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.2165/00019053-199813060-00006", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048200509", 
          "https://doi.org/10.2165/00019053-199813060-00006"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/jama.279.6.450", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048803673"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/jama.277.24.1962", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1054161127"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1126/science.3277273", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1062603638"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2307/135872", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1069444642"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.7326/0003-4819-114-9-798", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1073695493"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1074273632", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1075422566", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1075880389", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1077955878", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1079555624", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2000-10", 
    "datePublishedReg": "2000-10-01", 
    "description": "OBJECTIVE: To estimate survival, the number of life-years gained and cost effectiveness of antiretroviral therapy (ART) regimens, denoted as ERA-I [zidovudine + (didanosine or zalcitabine)]; ERA-II [stavudine + (didanosine or zalcitabine) or lamivudine + (zidovudine or didanosine or zalcitabine or stavudine)]; and ERA-III [2 nucleoside reverse transcriptase inhibitors + (1 protease inhibitor or 1 non-nucleoside reverse transcriptase inhibitor)].\nDESIGN: Modelling of drug cost, cost of opportunistic diseases and survival of HIV positive men and women in the province of British Columbia who were first prescribed any ART between October 1992 and June 1996. A 'reference cohort' was modelled upon individuals in a longitudinal cohort of homosexual men followed since 1982. PERSPECTIVE AND SETTING: Third-party payer perspective in British Columbia, Canada.\nPATIENTS: All HIV-positive men and women aged > or =18 years with CD4+ counts < or =350 cells/microL who were enrolled in the province-wide drug treatment programme.\nMAIN OUTCOME MEASURES: Annual costs, survival and cost-effectiveness ratios of successive ART regimens.\nRESULTS: Total costs [1997 Canadian dollars ($Can)] at 12 months under ERA-I, -II and -III were $Can4897, $Can6620 and $Can 11 914, respectively. Survival at 12 months under ERA-I, -II and -III was 89.6%, 91.0% and 97.6%, respectively. The annual incremental cost (estimated by the total incremental cost at 12 months) between ERA-II and ERA-I was $Can1723. The incremental cost-effectiveness ratios between ERA-III and ERA-I, and between ERA-III and ERA-II were $Can58 806 and $Can46 971 per life-year gained, respectively.\nCONCLUSION: We found the cost effectiveness of ERA-III ART regimens well within the range of currently funded therapies for the treatment of other chronic diseases.", 
    "genre": "research_article", 
    "id": "sg:pub.10.2165/00019053-200018040-00007", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1102812", 
        "issn": [
          "1170-7690", 
          "1179-2027"
        ], 
        "name": "PharmacoEconomics", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "4", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "18"
      }
    ], 
    "name": "The Cost Effectiveness of Antiretroviral Regimens for the Treatment of HIV/AIDS", 
    "pagination": "393-404", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "72b3607ca5271e8c3f9fadb8643553d840fb9d1d0ced07f38f5458292191f040"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "15344307"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "9212404"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.2165/00019053-200018040-00007"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1024075285"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.2165/00019053-200018040-00007", 
      "https://app.dimensions.ai/details/publication/pub.1024075285"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T12:35", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000363_0000000363/records_70027_00000000.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.2165/00019053-200018040-00007"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.2165/00019053-200018040-00007'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.2165/00019053-200018040-00007'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.2165/00019053-200018040-00007'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.2165/00019053-200018040-00007'


 

This table displays all metadata directly associated to this object as RDF triples.

240 TRIPLES      21 PREDICATES      60 URIs      31 LITERALS      19 BLANK NODES

Subject Predicate Object
1 sg:pub.10.2165/00019053-200018040-00007 schema:about N07a143c132154c3c8a8bc171cd644a75
2 N2d5bc069fd6b464fa9030bb461931c51
3 N38aeb1db09e04ad0a9f7bcdbe7bc35f7
4 N618ac3fec4ec43bfb49fa95816ab01ee
5 N973a5ef5ff0c4022bfabff9d177436a7
6 Nc1dfec96607d498aaf6bb1515df369b2
7 Nd46beeaf22b44782b4aac72474b257f9
8 Nef6609de11f4402196ec849e4f91b869
9 Nf9c7f36a9d12403e99b66c72006b577d
10 Nfca93f3c90564993acbb458967ff87c6
11 anzsrc-for:11
12 anzsrc-for:1117
13 schema:author Nddb0e2b7e9e54739bd6f551ee7f7cfc0
14 schema:citation sg:pub.10.2165/00019053-199610020-00001
15 sg:pub.10.2165/00019053-199610020-00002
16 sg:pub.10.2165/00019053-199712010-00006
17 sg:pub.10.2165/00019053-199813060-00006
18 https://app.dimensions.ai/details/publication/pub.1074273632
19 https://app.dimensions.ai/details/publication/pub.1075422566
20 https://app.dimensions.ai/details/publication/pub.1075880389
21 https://app.dimensions.ai/details/publication/pub.1077955878
22 https://app.dimensions.ai/details/publication/pub.1079555624
23 https://doi.org/10.1001/jama.1997.03540480062040
24 https://doi.org/10.1001/jama.277.24.1962
25 https://doi.org/10.1001/jama.279.2.130
26 https://doi.org/10.1001/jama.279.6.450
27 https://doi.org/10.1016/0277-9536(93)90315-u
28 https://doi.org/10.1017/s0266462300009247
29 https://doi.org/10.1097/00002030-198906000-00002
30 https://doi.org/10.1097/00002030-199803000-00005
31 https://doi.org/10.1097/00002030-199906180-00016
32 https://doi.org/10.1126/science.3277273
33 https://doi.org/10.2307/135872
34 https://doi.org/10.7326/0003-4819-114-9-798
35 schema:datePublished 2000-10
36 schema:datePublishedReg 2000-10-01
37 schema:description OBJECTIVE: To estimate survival, the number of life-years gained and cost effectiveness of antiretroviral therapy (ART) regimens, denoted as ERA-I [zidovudine + (didanosine or zalcitabine)]; ERA-II [stavudine + (didanosine or zalcitabine) or lamivudine + (zidovudine or didanosine or zalcitabine or stavudine)]; and ERA-III [2 nucleoside reverse transcriptase inhibitors + (1 protease inhibitor or 1 non-nucleoside reverse transcriptase inhibitor)]. DESIGN: Modelling of drug cost, cost of opportunistic diseases and survival of HIV positive men and women in the province of British Columbia who were first prescribed any ART between October 1992 and June 1996. A 'reference cohort' was modelled upon individuals in a longitudinal cohort of homosexual men followed since 1982. PERSPECTIVE AND SETTING: Third-party payer perspective in British Columbia, Canada. PATIENTS: All HIV-positive men and women aged > or =18 years with CD4+ counts < or =350 cells/microL who were enrolled in the province-wide drug treatment programme. MAIN OUTCOME MEASURES: Annual costs, survival and cost-effectiveness ratios of successive ART regimens. RESULTS: Total costs [1997 Canadian dollars ($Can)] at 12 months under ERA-I, -II and -III were $Can4897, $Can6620 and $Can 11 914, respectively. Survival at 12 months under ERA-I, -II and -III was 89.6%, 91.0% and 97.6%, respectively. The annual incremental cost (estimated by the total incremental cost at 12 months) between ERA-II and ERA-I was $Can1723. The incremental cost-effectiveness ratios between ERA-III and ERA-I, and between ERA-III and ERA-II were $Can58 806 and $Can46 971 per life-year gained, respectively. CONCLUSION: We found the cost effectiveness of ERA-III ART regimens well within the range of currently funded therapies for the treatment of other chronic diseases.
38 schema:genre research_article
39 schema:inLanguage en
40 schema:isAccessibleForFree false
41 schema:isPartOf N78b96ee81bd8414baacc92134f33c630
42 Nd52d8b47cbf9412099b7e1c7de589558
43 sg:journal.1102812
44 schema:name The Cost Effectiveness of Antiretroviral Regimens for the Treatment of HIV/AIDS
45 schema:pagination 393-404
46 schema:productId N28ff984deb7841f7a2d7fa0524939a77
47 N2ed78b6fcbeb4c5cbf73fef083d3521e
48 N6b7a1abff09b45a4a1a442ec26aeb78e
49 Ndc6fc64ebf0c4db8bc3ee75678b7f268
50 Nea8717a29c0446db92241e65d83ac61e
51 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024075285
52 https://doi.org/10.2165/00019053-200018040-00007
53 schema:sdDatePublished 2019-04-11T12:35
54 schema:sdLicense https://scigraph.springernature.com/explorer/license/
55 schema:sdPublisher N59ea4d5f74554d8fae3f93b8271658f9
56 schema:url http://link.springer.com/10.2165/00019053-200018040-00007
57 sgo:license sg:explorer/license/
58 sgo:sdDataset articles
59 rdf:type schema:ScholarlyArticle
60 N07a143c132154c3c8a8bc171cd644a75 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
61 schema:name Humans
62 rdf:type schema:DefinedTerm
63 N28ff984deb7841f7a2d7fa0524939a77 schema:name pubmed_id
64 schema:value 15344307
65 rdf:type schema:PropertyValue
66 N2d5bc069fd6b464fa9030bb461931c51 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
67 schema:name Health Care Costs
68 rdf:type schema:DefinedTerm
69 N2ed78b6fcbeb4c5cbf73fef083d3521e schema:name readcube_id
70 schema:value 72b3607ca5271e8c3f9fadb8643553d840fb9d1d0ced07f38f5458292191f040
71 rdf:type schema:PropertyValue
72 N38aeb1db09e04ad0a9f7bcdbe7bc35f7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
73 schema:name Acquired Immunodeficiency Syndrome
74 rdf:type schema:DefinedTerm
75 N482ae8d6a0874642984461ae20141676 rdf:first sg:person.01133246574.60
76 rdf:rest N74b261d687ce4535b0690973bdd16e36
77 N551169875997473eb63b90118f77dcd3 rdf:first sg:person.015212221772.29
78 rdf:rest rdf:nil
79 N58f9a8927f064f2aa146a5caee77f844 rdf:first sg:person.0654122412.16
80 rdf:rest N7a10887c336942c58183d9463c64af4e
81 N59ea4d5f74554d8fae3f93b8271658f9 schema:name Springer Nature - SN SciGraph project
82 rdf:type schema:Organization
83 N5fccb30ff47d46028fabf12c64b678be rdf:first sg:person.0663251475.19
84 rdf:rest Ne95b8dd975d34491a76282d70522a6c7
85 N618ac3fec4ec43bfb49fa95816ab01ee schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
86 schema:name Cost-Benefit Analysis
87 rdf:type schema:DefinedTerm
88 N6b7a1abff09b45a4a1a442ec26aeb78e schema:name doi
89 schema:value 10.2165/00019053-200018040-00007
90 rdf:type schema:PropertyValue
91 N74b261d687ce4535b0690973bdd16e36 rdf:first sg:person.01160746452.90
92 rdf:rest Nd1ec0c51fea8457081289c61d17c1f70
93 N78b96ee81bd8414baacc92134f33c630 schema:volumeNumber 18
94 rdf:type schema:PublicationVolume
95 N7a10887c336942c58183d9463c64af4e rdf:first sg:person.01057070102.49
96 rdf:rest N482ae8d6a0874642984461ae20141676
97 N973a5ef5ff0c4022bfabff9d177436a7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
98 schema:name Middle Aged
99 rdf:type schema:DefinedTerm
100 Na9cd341f31344229b442bca0f17b3e74 schema:name Canadian HIV Trials Network, Vancouver, British Columbia, Canada
101 rdf:type schema:Organization
102 Nc1dfec96607d498aaf6bb1515df369b2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
103 schema:name Male
104 rdf:type schema:DefinedTerm
105 Nd1ec0c51fea8457081289c61d17c1f70 rdf:first sg:person.01211241175.66
106 rdf:rest N5fccb30ff47d46028fabf12c64b678be
107 Nd46beeaf22b44782b4aac72474b257f9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
108 schema:name Adult
109 rdf:type schema:DefinedTerm
110 Nd52d8b47cbf9412099b7e1c7de589558 schema:issueNumber 4
111 rdf:type schema:PublicationIssue
112 Ndc6fc64ebf0c4db8bc3ee75678b7f268 schema:name dimensions_id
113 schema:value pub.1024075285
114 rdf:type schema:PropertyValue
115 Nddb0e2b7e9e54739bd6f551ee7f7cfc0 rdf:first sg:person.01340462506.44
116 rdf:rest N58f9a8927f064f2aa146a5caee77f844
117 Ndf5518c17d63422fa67e7cf0cfc4552e schema:name Canadian HIV Trials Network, Vancouver, British Columbia, Canada
118 rdf:type schema:Organization
119 Ne95b8dd975d34491a76282d70522a6c7 rdf:first sg:person.016444275112.20
120 rdf:rest N551169875997473eb63b90118f77dcd3
121 Nea8717a29c0446db92241e65d83ac61e schema:name nlm_unique_id
122 schema:value 9212404
123 rdf:type schema:PropertyValue
124 Nef6609de11f4402196ec849e4f91b869 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
125 schema:name Female
126 rdf:type schema:DefinedTerm
127 Nf9c7f36a9d12403e99b66c72006b577d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
128 schema:name Drug Therapy, Combination
129 rdf:type schema:DefinedTerm
130 Nfc079d0eb2df482ca8a1c0763b6dd869 schema:name Canadian HIV Trials Network, Vancouver, British Columbia, Canada
131 rdf:type schema:Organization
132 Nfca93f3c90564993acbb458967ff87c6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
133 schema:name Anti-HIV Agents
134 rdf:type schema:DefinedTerm
135 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
136 schema:name Medical and Health Sciences
137 rdf:type schema:DefinedTerm
138 anzsrc-for:1117 schema:inDefinedTermSet anzsrc-for:
139 schema:name Public Health and Health Services
140 rdf:type schema:DefinedTerm
141 sg:journal.1102812 schema:issn 1170-7690
142 1179-2027
143 schema:name PharmacoEconomics
144 rdf:type schema:Periodical
145 sg:person.01057070102.49 schema:affiliation https://www.grid.ac/institutes/grid.17091.3e
146 schema:familyName Hogg
147 schema:givenName Robert S.
148 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01057070102.49
149 rdf:type schema:Person
150 sg:person.01133246574.60 schema:affiliation Na9cd341f31344229b442bca0f17b3e74
151 schema:familyName Wang
152 schema:givenName Xiao-Hua
153 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01133246574.60
154 rdf:type schema:Person
155 sg:person.01160746452.90 schema:affiliation https://www.grid.ac/institutes/grid.416553.0
156 schema:familyName Yip
157 schema:givenName Benita
158 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01160746452.90
159 rdf:type schema:Person
160 sg:person.01211241175.66 schema:affiliation Ndf5518c17d63422fa67e7cf0cfc4552e
161 schema:familyName Craib
162 schema:givenName Kevin J. P.
163 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01211241175.66
164 rdf:type schema:Person
165 sg:person.01340462506.44 schema:affiliation https://www.grid.ac/institutes/grid.17091.3e
166 schema:familyName Anis
167 schema:givenName Aslam H.
168 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01340462506.44
169 rdf:type schema:Person
170 sg:person.015212221772.29 schema:affiliation https://www.grid.ac/institutes/grid.17091.3e
171 schema:familyName Montaner
172 schema:givenName Julio S. G.
173 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015212221772.29
174 rdf:type schema:Person
175 sg:person.016444275112.20 schema:affiliation https://www.grid.ac/institutes/grid.17091.3e
176 schema:familyName Schechter
177 schema:givenName Martin T.
178 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016444275112.20
179 rdf:type schema:Person
180 sg:person.0654122412.16 schema:affiliation Nfc079d0eb2df482ca8a1c0763b6dd869
181 schema:familyName Guh
182 schema:givenName Daphne
183 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0654122412.16
184 rdf:type schema:Person
185 sg:person.0663251475.19 schema:affiliation https://www.grid.ac/institutes/grid.17091.3e
186 schema:familyName O’Shaughnessy
187 schema:givenName Michael V.
188 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0663251475.19
189 rdf:type schema:Person
190 sg:pub.10.2165/00019053-199610020-00001 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005281811
191 https://doi.org/10.2165/00019053-199610020-00001
192 rdf:type schema:CreativeWork
193 sg:pub.10.2165/00019053-199610020-00002 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029089270
194 https://doi.org/10.2165/00019053-199610020-00002
195 rdf:type schema:CreativeWork
196 sg:pub.10.2165/00019053-199712010-00006 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003832056
197 https://doi.org/10.2165/00019053-199712010-00006
198 rdf:type schema:CreativeWork
199 sg:pub.10.2165/00019053-199813060-00006 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048200509
200 https://doi.org/10.2165/00019053-199813060-00006
201 rdf:type schema:CreativeWork
202 https://app.dimensions.ai/details/publication/pub.1074273632 schema:CreativeWork
203 https://app.dimensions.ai/details/publication/pub.1075422566 schema:CreativeWork
204 https://app.dimensions.ai/details/publication/pub.1075880389 schema:CreativeWork
205 https://app.dimensions.ai/details/publication/pub.1077955878 schema:CreativeWork
206 https://app.dimensions.ai/details/publication/pub.1079555624 schema:CreativeWork
207 https://doi.org/10.1001/jama.1997.03540480062040 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028003169
208 rdf:type schema:CreativeWork
209 https://doi.org/10.1001/jama.277.24.1962 schema:sameAs https://app.dimensions.ai/details/publication/pub.1054161127
210 rdf:type schema:CreativeWork
211 https://doi.org/10.1001/jama.279.2.130 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045751367
212 rdf:type schema:CreativeWork
213 https://doi.org/10.1001/jama.279.6.450 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048803673
214 rdf:type schema:CreativeWork
215 https://doi.org/10.1016/0277-9536(93)90315-u schema:sameAs https://app.dimensions.ai/details/publication/pub.1009374126
216 rdf:type schema:CreativeWork
217 https://doi.org/10.1017/s0266462300009247 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024918358
218 rdf:type schema:CreativeWork
219 https://doi.org/10.1097/00002030-198906000-00002 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004321333
220 rdf:type schema:CreativeWork
221 https://doi.org/10.1097/00002030-199803000-00005 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013608384
222 rdf:type schema:CreativeWork
223 https://doi.org/10.1097/00002030-199906180-00016 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020821681
224 rdf:type schema:CreativeWork
225 https://doi.org/10.1126/science.3277273 schema:sameAs https://app.dimensions.ai/details/publication/pub.1062603638
226 rdf:type schema:CreativeWork
227 https://doi.org/10.2307/135872 schema:sameAs https://app.dimensions.ai/details/publication/pub.1069444642
228 rdf:type schema:CreativeWork
229 https://doi.org/10.7326/0003-4819-114-9-798 schema:sameAs https://app.dimensions.ai/details/publication/pub.1073695493
230 rdf:type schema:CreativeWork
231 https://www.grid.ac/institutes/grid.17091.3e schema:alternateName University of British Columbia
232 schema:name British Columbia Centre for Excellence in HIV/AIDS, St. Paul’s Hospital, Vancouver, British Columbia, Canada
233 Canadian HIV Trials Network, Vancouver, British Columbia, Canada
234 Department of Health Care and Epidemiology, University of British Columbia, Vancouver, British Columbia, Canada
235 Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada
236 Department of Pathology, University of British Columbia, Vancouver, British Columbia, Canada
237 rdf:type schema:Organization
238 https://www.grid.ac/institutes/grid.416553.0 schema:alternateName St. Paul's Hospital
239 schema:name British Columbia Centre for Excellence in HIV/AIDS, St. Paul’s Hospital, Vancouver, British Columbia, Canada
240 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...